Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Federal Trade Commission

Generated: December 16, 2017

DrugPatentWatch Database Preview

TORSEMIDE Drug Profile

« Back to Dashboard

When do Torsemide patents expire, and when can generic versions of Torsemide launch?

Torsemide is a drug marketed by Luitpold, West-ward Pharms Int, Apotex Inc, Aurobindo Pharma, Hetero Labs Ltd Iii, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms. and is included in eleven NDAs.

The generic ingredient in TORSEMIDE is torsemide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TevaTORSEMIDEtorsemideTABLET;ORAL076110-004May 14, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm IndsTORSEMIDEtorsemideTABLET;ORAL078478-004Feb 26, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Vintage PharmsTORSEMIDEtorsemideTABLET;ORAL090613-001Mar 22, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaTORSEMIDEtorsemideTABLET;ORAL076110-001May 14, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
LuitpoldTORSEMIDEtorsemideINJECTABLE;INJECTION090656-001Apr 21, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Par PharmTORSEMIDEtorsemideTABLET;ORAL076226-002May 27, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Pliva Pharm IndTORSEMIDEtorsemideTABLET;ORAL076346-004Oct 19, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntTORSEMIDEtorsemideTABLET;ORAL076943-003Mar 1, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncTORSEMIDEtorsemideTABLET;ORAL076894-003May 31, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Vintage PharmsTORSEMIDEtorsemideTABLET;ORAL090613-004Mar 22, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: